
Scientific Opinion on the assessment of the control measures for category A diseases of Animal Health Law: Foot and Mouth Disease
Author(s) -
Nielsen Søren Saxmose,
Alvarez Julio,
Bicout Dominique Joseph,
Calistri Paolo,
Canali Elisabetta,
Drewe Julian Ashley,
GarinBastuji Bruno,
Gonzales Rojas José Luis,
Gortázar Schmidt Christian,
Herskin Mette,
Michel Virginie,
Miranda Chueca Miguel Ángel,
Padalino Barbara,
Pasquali Paolo,
Sihvonen Liisa Helena,
Spoolder Hans,
Ståhl Karl,
Velarde Antonio,
Viltrop Arvo,
Winckler Christoph,
De Clercq Kris,
Gubbins Simon,
Klement Eyal,
Stegeman Jan Arend,
Antoniou SotiriaEleni,
Aznar Inma,
Broglia Alessandro,
Papanikolaou Alexandra,
Van der Stede Yves,
Zancanaro Gabriele,
Roberts Helen Clare
Publication year - 2021
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2021.6632
Subject(s) - health claims on food labels , animal health , animal welfare , library science , veterinary medicine , law , medicine , political science , biology , food science , computer science , ecology
EFSA received a mandate from the European Commission to assess the effectiveness of some of the control measures against diseases included in the Category A list according to Regulation ( EU ) 2016/429 on transmissible animal diseases (‘Animal Health Law’). This opinion belongs to a series of opinions where these control measures will be assessed, with this opinion covering the assessment of control measures for foot and mouth disease ( FMD ). In this opinion, EFSA and the AHAW Panel of experts review the effectiveness of: i) clinical and laboratory sampling procedures, ii) monitoring period and iii) the minimum radius of the protection and surveillance zones, and the minimum length of time the measures should be applied in these zones. The general methodology used for this series of opinions has been published elsewhere; nonetheless, the transmission kernels used for the assessment of the minimum radius of the protection zone of 3 km and of the surveillance zone of 10 km are shown. Several scenarios for which these control measures had to be assessed were designed and agreed prior to the start of the assessment. The monitoring period of 21 days was assessed as effective, and it was concluded that the protection and the surveillance zones comprise > 99% of the infections from an affected establishment if transmission occurred. Recommendations, provided for each of the scenarios assessed, aim to support the European Commission in the drafting of further pieces of legislation, as well as for plausible ad hoc requests in relation to FMD .